• Target

    £1,500,000

  • Type

    Equity

  • Close Date

    Mar 31 2020

  • Status

    Open

RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.

Ablatus Limited

Ablatus Therapeutics is a MedTech company that is developing a unique tissue ablation platform - Bimodal Electric Tissue Ablation (BETA).

Investment closes only once the total pledged amount passes the minimum of £1,000,000

Total Pledged: £600,000
Max

£1,500,000

£

A pledge is not a commitment. You will be asked to confirm in the next section.

Track
Contact
Companies
House
Twitter

Overview

Ablatus Therapeutics is a MedTech company that is developing a unique tissue ablation platform - Bimodal Electric Tissue Ablation (BETA). This technology overcomes the limitations of existing products, offering ablation solutions in oncology (tumours) and non-oncology targets such as fibroids, pain management and renal denervation for hypertension, where existing technology cannot.

Tissue ablation is a minimally invasive image-guided surgical technique, in which diseased tissue such as tumours, are killed through the delivery of energy. A needle-like probe is placed inside the target and energy applied heats and destroys the tissue. Essentially, ablation ‘cooks instead of cuts’. Currently, ablation is limited in terms of the size and location of tumours which can be treated.

BETA was originally developed within the Norfolk and Norwich University Hospital NHS Foundation Trust and spun out of the hospital as Ablatus Therapeutics in May 2016, with £495k of initial investment.
  • Sector: Healthcare
  • Region: UK: London
  • Stage: Other
  • Eligible Tax: EIS
  • Board Requirement:
  • Pre Money Valuation: £4,000,000
  • Share Price: £1.29
  • Originator: Envestors
This section is currently locked.
Please Sign Up or Log In to unlock.

Team

This section is currently locked.
Please Sign Up or Log In to unlock.

Market

This section is currently locked.
Please Sign Up or Log In to unlock.

Investment

This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Documents

13 documents are currently locked.
To unlock the Data Room you will need to Sign Up or Login

Originator


Originator: Envestors

Investment Focus: Equity and Debt

About: Envestors is a FCA regulated corporate finance adviser in the UK and operates an international network of sophisticated investors investing an average of £42,000 in high growth unquoted companies seeking £250,000 to £2m in equity funding.

Contact Name: Oliver Woolley

  • Registered Investors
    Over 1000
  • Investment through platform
    Over £100m